| Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine. | |
| | |
MedLine Citation:
|
PMID: 16865267 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Several lines of evidence suggest that stem cells are major targets for carcinogens. A normal human breast epithelial cell type was previously shown to possess stem cell characteristics. Further cell lines were derived following sequential transfection with SV40 large T-antigen (immortal, non-tumorigenic M13SV1 cells), exposure to X-rays (weakly tumorigenic M13SV1R2 cells), and ectopic expression of c-erbB2/neu (highly tumorigenic M13SV1R2N1 cells). We evaluated some characteristics of these cells and their susceptibility to the breast carcinogen 7,12-dimethylbenz(a)anthracene (DMBA). Compared to M13SV1 cells, the two untreated tumorigenic cell lines displayed higher levels of connexin 43 expression and NF-kappaB nuclear translocation, and a higher frequency of fhit loss. The baseline nuclear translocation of AP-1 and pCREB was particularly evident in M13SV1R2N1 cells and was further enhanced by DMBA treatment, indicating an interaction between c-erbB2/neu and DMBA-induced signalling. Treatment with DMBA did neither affect the baseline fhit loss nor p53 mutation, whereas it increased NF-kappaB nuclear translocation, the proportion of apoptotic cells, and the levels of connexin 43, common 4977-bp mitochondrial DNA deletion, and bulky adducts to nuclear DNA. DMBA-treated M13SV1 cells underwent significant oxidative DNA damage and exhibited the highest DNA adduct levels, while they had the lowest apoptotic rate. Co-treatment of cells with N-acetylcysteine (NAC) attenuated DMBA-induced toxicity and DNA alterations, particularly in M13SV1 cells. Thus, the immortal cell line derived from the normal human adult breast stem cell without further tumorigenic progression is the most susceptible both to DMBA-related alterations and to the protective effects of NAC. |
| | |
Authors:
|
Silvio De Flora; Sonia Scarfì; Alberto Izzotti; Francesco D'Agostini; Chia-Cheng Chang; Maria Bagnasco; Antonio De Flora; James E Trosko |
Related Documents
:
|
12482987 - Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. 1428087 - Chemically induced cell proliferation in carcinogenesis. 14715257 - 9-hydroxystearic acid upregulates p21(waf1) in ht29 cancer cells. 2267137 - Subcellular distribution of the p53 protein during the cell cycle of balb/c 3t3 cells. 3404997 - Evidence for an intraclonal random shift between two types of cell cycle times in an em... 8655707 - Parietal cells in the duodenal bulb and their relation to helicobacter pylori infection. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of oncology Volume: 29 ISSN: 1019-6439 ISO Abbreviation: Int. J. Oncol. Publication Date: 2006 Sep |
Date Detail:
|
Created Date: 2006-07-25 Completed Date: 2006-10-05 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 9306042 Medline TA: Int J Oncol Country: Greece |
Other Details:
|
Languages: eng Pagination: 521-9 Citation Subset: IM |
Affiliation:
|
Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa, I-16132 Genoa, Italy. sdf@unige.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
9,10-Dimethyl-1,2-benzanthracene
/
toxicity* Acetylcysteine / pharmacology* Acid Anhydride Hydrolases / metabolism Apoptosis / drug effects Carcinogens / toxicity* Cell Line, Transformed Cell Nucleus Cells, Cultured Connexin 43 / metabolism Epithelial Cells / drug effects*, metabolism Free Radical Scavengers / pharmacology* Humans Mammary Glands, Human / drug effects*, metabolism NF-kappa B / genetics, metabolism Neoplasm Proteins / metabolism Protein Transport Receptor, erbB-2 / metabolism Stem Cells / drug effects*, metabolism Tumor Suppressor Protein p53 / genetics, metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
PA42 ES049111/ES/NIEHS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Carcinogens; 0/Connexin 43; 0/Free Radical Scavengers; 0/NF-kappa B; 0/Neoplasm Proteins; 0/Tumor Suppressor Protein p53; 0/fragile histidine triad protein; 57-97-6/9,10-Dimethyl-1,2-benzanthracene; 616-91-1/Acetylcysteine; EC 2.7.10.1/Receptor, erbB-2; EC 3.6.-/Acid Anhydride Hydrolases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The impact of hyperthermic chemotherapy on human gastric cancer cell lines: preliminary results.
Next Document: Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell...